期刊文献+

SCORTEN评分对中毒性表皮坏死松解症和Stevens-Johnson综合征评估分析 被引量:6

Prognostic accuracy of the SCORTEN scoring system in patients with toxic epidermal necrolysis or Stevens-Johnson syndrome
原文传递
导出
摘要 目的 分析SCORTEN评分对中毒性表皮坏死松解症和Stevens-Johnson综合征患者预后评估的准确性。方法 回顾性分析1992年4月至2014年3月期间在北京协和医院收治的中毒性表皮坏死松解症和Stevens-Johnson综合征39例,其中死亡病例13例,按照年龄分层1∶2匹配诊断明确好转出院26例。39例患者用SCORTEN评分系统评分,计算预期死亡数,比较39例各级分层的预期死亡数与实际死亡数,绘制受试者工作特征曲线(ROC曲线),评估SCORTEN评分的判断力。结果 39例患者中,按SCORTEN评分系统评为1分15例,2分14例,3分6例,4分4例,总预期死亡6.808例,实际死亡13例。 每个积分层预期死亡数与实际死亡数差异无统计学意义。SCORTEN评分系统的ROC曲线下面积 = 0.832 8,表明有较好的预测能力。结论 SCORTEN评分系统可在早期对中毒性表皮坏死松解症和Stevens-Johnson综合征患者死亡率作出评估。 Objective To evaluate the prognostic accuracy of the score of toxic epidermal necrolysis (SCORTEN) scoring system in patients with toxic epidermal necrolysis (TEN) or Stevens-Johnson syndrome (SJS). Methods Clinical data were collected from 39 patients with SJS/TEN hospitalized in Peking Union Medical College Hospital during April 1992 and March 2014, and retrospectively analyzed. Among the 39 patients, 13 had died, and the other 26 patients, who were matched to the dead patients in a ratio of 2∶1 for age, all had a definite diagnosis and were discharged with improved conditions. The SCORTEN scoring system was used to evaluate the 39 patients with SJS/TEN and calculate expected mortality. The expected mortality and actual mortality were compared between different groups stratified by age in the 39 patients. The receiver operating characteristic (ROC) curve was drawn to assess the prognostic accuracy of the SCORTEN scoring system. Results According to the SCORTEN scoring system, 15 out of the 39 patients scored 1 point, 14 scored 2 points, 6 scored 3 points, and 4 scored 4 points. The total number of expected deaths was 6.808, while that of actual deaths was 13. There was no significant difference between the expected mortality and actual mortality in every SCORTEN score-based group. The area under curve (AUC) was 0.832 8, indicating a good predictive ability of the SCORTEN scoring system. Conclusion The SCORTEN scoring system can predict mortality in TEN/SJS patients at early stage.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2016年第9期651-653,共3页 Chinese Journal of Dermatology
基金 基金项目:国家自然科学基金(81071301) 北京市自然科学基金(7132203)
关键词 表皮坏死松解症 中毒性 药疹 STEVENS-JOHNSON综合征 SCORTEN评分 Epidermal necrolysis, toxic Drug eruptions Stevens-Johnson syndrome SCORTEN
  • 相关文献

参考文献14

  • 1Bansal S, Garg VK, Sardana K, et al. A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of score of toxic epidermal necrolysis [J]. Int J Dermatol, 2015, 54 (1): e18-26. DOI: 10.1111/ijd.12466.
  • 2Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis [J ]. J Invest Dermatol, 2000, 115 (2): 149- 153. DOI: 10.1046/j.1523- 1747.2000.00061 .x.
  • 3Cartotto R, Mayich M, Nickerson D, et al. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center[J]. J Burn Care Res, 2008, 29( 1 ): 141- 146. DOI: lO.1097/BCR.ObO13e31815f3865.
  • 4Imahara SD, Holmes JH, Heimbach DM, et al. SCORTEN overestimates mortality in the setting of a standardized treatment protocol [J]. J Burn Care Res, 2006, 27 (3): 270-275.
  • 5Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens- Johnson syndrome, and erythema muhiforme[J]. Arch Dermatol, 1993, 129 ( 1): 92- 96.
  • 6Sekula P, Liss Y, Davidovici B, et al. Evaluation of SCORTEN on a cohort of patients with Stevens- Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study[J]. J Burn Care Res, 2011, 32 (2): 237- 245. DOI: 10.1097/BCR. 0b013e31820aafbc.
  • 7Vaishampayan SS, Das AL, Verma R. SCORTEN: does it need modification? [J]. Indian J Dermatol Venereol Leprol, 2008, 74 (1): 35-37.
  • 8Trent JT, Kirsner RS, Romanelli P, et al. Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States [J]. Arch Dermatol, 2004, 140(7): 890-892. DOI: 10.1001/archderm. 140.7.890.
  • 9Morales ME, Purdue GF, Verity SM, et al. Ophthalmic manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN [J]. Am J Ophthalmol, 2010, 150(4): 505-510.el. DOI: 10.1016/j.ajo.2010.04.026.
  • 10杨永生,徐金华,朱小华,林尽染,梁俊.SCORTEN评分系统评估重症大疱性药疹的可行性分析[J].临床皮肤科杂志,2011,40(1):19-20. 被引量:10

二级参考文献9

  • 1Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema muhiforme[J]. Arch Dennatol, 1993, 129(1 ) : 92-96.
  • 2Auquier-Dunant A, Mockenhaupt M, Naldi L, et al. Severe Cutaneous Adverse Reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study[J]. Arch Dermatol, 2002, 138(8): 1019-1024.
  • 3Assier H, Bastuji-Garin S, Revuz J, et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes[J]. Arch Dermatol, 1995, 131(5) : 539-543.
  • 4Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis[J]. J Invest Dermatol, 2000, 115(2): 149-153.
  • 5Guegan S, Bastuji-Garin S, Poszepczynska-Guigne E, et al. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis[J]. J Invest Dermatol, 2006, 126(2) : 272-276.
  • 6Cartotto R, Mayich M, Nickerson D, et al. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center[J]. J Burn Care Res, 2008, 29( 1 ) : 141-146.
  • 7Trent JT, Kirsner RS, Romanelli P, et al. Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States[J]. Arch Dermatol, 2004, 140(7) : 890-892.
  • 8Chave TA, Mortimer N J, Sladden M J, et al. Toxic epidermal necrolysis: current evidence, practical management and future directions [J]. BrJ Dermatol, 2005, 153(2) : 241-253.
  • 9Khalili B, Bahna SL. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Ann Allergy Asthma Immunol, 2006, 97 (3) : 272-280, 281-283, 320.

共引文献9

同被引文献21

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部